Global Clostridium Difficile Treatment Market Status and Outlook 2018-2025

August 2018 | 140 pages | ID: GE77A03B602EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Actelion Pharmaceuticals
• Merck
• Pfizer
• Summit Therapeutics
• Astellas Pharma
• CRESTOVO
• Da Volterra
• Immuron
• MGB Biopharma
• Novartis
• Otsuka Pharmaceutical
• Rebiotix
• Romark Laboratories
• Sanofi Pasteur
• Seres Therapeutics
• Shire
• Synthetic Biologics
• Valeant Pharmaceuticals
• Valneva

Market by Type

• Narrow Spectrum Antibiotics
• Broad Spectrum Antibiotics

Market by Application

• Hospitals
• Clinics
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Clostridium Difficile Treatment Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Narrow Spectrum Antibiotics
  3.1.2 Broad Spectrum Antibiotics
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospitals
  4.1.2 Clinics
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Narrow Spectrum Antibiotics Production by Region
    6.1.1.2 Broad Spectrum Antibiotics Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospitals Production by Region
    6.1.2.2 Clinics Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Narrow Spectrum Antibiotics Demand by Region
    6.2.1.2 Broad Spectrum Antibiotics Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospitals Demand by Region
    6.2.2.2 Clinics Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Actelion Pharmaceuticals
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merck
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Pfizer
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Summit Therapeutics
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Astellas Pharma
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 CRESTOVO
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Da Volterra
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Immuron
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 MGB Biopharma
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Novartis
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Otsuka Pharmaceutical
8.12 Rebiotix
8.13 Romark Laboratories
8.14 Sanofi Pasteur
8.15 Seres Therapeutics
8.16 Shire
8.17 Synthetic Biologics
8.18 Valeant Pharmaceuticals
8.19 Valneva

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Clostridium Difficile Treatment Industry Dynamics & Regulations List
Table Global Clostridium Difficile Treatment Sales Revenue, Cost and Margin, 2015-2018E
Table Global Clostridium Difficile Treatment Market Status by Type 2015-2018E, in USD Million
Table Global Clostridium Difficile Treatment Market Status by Application 2015-2018E, in USD Million
Table Global Clostridium Difficile Treatment Market Status by Application 2015-2018E, in Volume
Table Global Clostridium Difficile Treatment Market by Region 2015-2018E, in USD Million
Table Global Clostridium Difficile Treatment Market Share by Region in 2018, in USD Million
Table Global Clostridium Difficile Treatment Market by Region 2015-2018E, in Volume
Table Global Clostridium Difficile Treatment Market Share by Region in 2018, in Volume
Table Narrow Spectrum Antibiotics Production Value by Region 2015-2018E, in USD Million
Table Narrow Spectrum Antibiotics Production Volume by Region 2015-2018E, in Volume
Table Broad Spectrum Antibiotics Production Value by Region 2015-2018E, in USD Million
Table Broad Spectrum Antibiotics Production Volume by Region 2015-2018E, in Volume
Table Hospitals Production Value by Region 2015-2018E, in USD Million
Table Hospitals Production Volume by Region 2015-2018E, in Volume
Table Clinics Production Value by Region 2015-2018E, in USD Million
Table Clinics Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Narrow Spectrum Antibiotics Market Size by Region 2015-2018E, in USD Million
Table Narrow Spectrum Antibiotics Market Size by Region 2015-2018E, in Volume
Table Broad Spectrum Antibiotics Market Size by Region 2015-2018E, in USD Million
Table Broad Spectrum Antibiotics Market Size by Region 2015-2018E, in Volume
Table Hospitals Market Size by Region 2015-2018E, in USD Million
Table Hospitals Market Size by Region 2015-2018E, in Volume
Table Clinics Market Size by Region 2015-2018E, in USD Million
Table Clinics Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalClostridium Difficile Treatment Forecast by Type 2019F-2025F, in USD Million
Table Clostridium Difficile Treatment Forecast by Type 2019F-2025F, in Volume
Table Clostridium Difficile Treatment Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Clostridium Difficile Treatment Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Clostridium Difficile Treatment Market Forecast by Region 2019F-2025F, in USD Million
Table Clostridium Difficile Treatment Market Forecast by Region 2019F-2025F, in Volume
Table Actelion Pharmaceuticals Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Actelion Pharmaceuticals
Table Merck Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Merck
Table Pfizer Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Pfizer
Table Summit Therapeutics Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Summit Therapeutics
Table Astellas Pharma Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Astellas Pharma
Table CRESTOVO Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of CRESTOVO
Table Da Volterra Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Da Volterra
Table Immuron Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Immuron
Table MGB Biopharma Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of MGB Biopharma
Table Novartis Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Novartis
Table Otsuka Pharmaceutical Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Otsuka Pharmaceutical
Table Rebiotix Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Rebiotix
Table Romark Laboratories Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Romark Laboratories
Table Sanofi Pasteur Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Sanofi Pasteur
Table Seres Therapeutics Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Seres Therapeutics
Table Shire Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Shire
Table Synthetic Biologics Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Synthetic Biologics
Table Valeant Pharmaceuticals Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Valeant Pharmaceuticals
Table Valneva Information
Table Clostridium Difficile Treatment Sales, Cost, Margin of Valneva
Table Global Clostridium Difficile Treatment Sales Revenue by Company 2015-2017, in USD Million
Table Global Clostridium Difficile Treatment Sales Volume by Company 2015-2017, in Volume
Table Global Clostridium Difficile Treatment Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Clostridium Difficile Treatment Picture
Figure Clostridium Difficile Treatment Industry Chain Diagram
Figure Global Clostridium Difficile Treatment Sales Revenue 2015-2018E, in USD Million
Figure Global Clostridium Difficile Treatment Sales Volume 2015-2018E, in Volume
Figure Global Clostridium Difficile Treatment Market Status by Type 2015-2018E, in Volume
Figure North America Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in USD Million
Figure North America Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in Volume
Figure Europe Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Europe Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in Volume
Figure South America Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in USD Million
Figure South America Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in Volume
Figure Middle East Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in Volume
Figure Africa Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Africa Clostridium Difficile Treatment Market Size and Growth 2015-2018E, in Volume
Figure Global Clostridium Difficile Treatment Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Clostridium Difficile Treatment Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Clostridium Difficile Treatment Sales Price Forecast 2019F-2025F
Figure Global Clostridium Difficile Treatment Gross Margin Forecast 2019F-2025F
Figure Global Clostridium Difficile Treatment Sales Revenue by Company in 2018, in USD Million
Figure Global Clostridium Difficile Treatment Price by Company in 2018
Figure Global Clostridium Difficile Treatment Gross Margin by Company in 2018